Lamaline Side Effects

8023068-2 | Cytolytic Hepatitis
on Jan 02, 2012 Female patient from FRANCE , 34 years of age, was treated with Lamaline(View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis. Lamaline dosage: Single Intake Of 80 Tablets. During the same period patient was treated with XANAX (.25 Mg, 60 Tablets) (View Xanax Review and Xanax Label ), ESCITALOPRAM (Unk) (View Escitalopram Review and Escitalopram Label ). Patient was hospitalized.

8010189-3 | Orthostatic Hypotension, Malaise, Fall, Disorientation, Bundle Branch Block Right
Patient was taking Lamaline (View Usage). Patient had the following side effects: orthostatic hypotension, malaise, fall (What is fall?), disorientation, bundle branch block right on Dec 06, 2011 from FRANCE Additional patient health information: Female patient , 71 years of age, . Lamaline dosage: . During the same period patient was treated with FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ), AZOPT (Ophthalmic) (View Azopt Review and Azopt Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), LYRICA (View Lyrica Review and Lyrica Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ESCITALOPRAM OXALATE (View Escitalopram Oxalate Review and Escitalopram Oxalate Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), FLUTICASONE PROPIONATE/SALMETEROL (View Fluticasone Propionate/salmeterol Review and Fluticasone Propionate/salmeterol Label ). Patient was hospitalized.

7953018-6 | Raynaud's Phenomenon
Adverse event was reported on Nov 29, 2011 by a Female patient taking Lamaline (View Usage) (Dosage: Unk) was diagnosed with pain (What is pain?), migraine (What is migraine?), depression (What is depression?) and. Location: FRANCE , 44 years of age, weighting 110.2 lb, After Lamaline was administered, patient had the following side effects: raynaud's phenomenon. During the same period patient was treated with IBUPROFEN (200 Mg, 1x/day) (View Ibuprofen Review and Ibuprofen Label ), RELPAX (40mg 10 Tablets Per Month) (View Relpax Review and Relpax Label ), ESCITALOPRAM (10 Mg, 1x/day) (View Escitalopram Review and Escitalopram Label ).

7829611-8 | Cervical Dysplasia, Cervicitis Human Papilloma Virus
on Oct 10, 2011 Female patient from FRANCE , 42 years of age, weighting 180.8 lb, was diagnosed with pain (What is pain?), ankylosing spondylitis (What is ankylosing spondylitis?), abdominal pain upper, inflammation and was treated with Lamaline /00764901/ (View Usage). Patient experienced the following unwanted or unexpected effects: cervical dysplasia, cervicitis human papilloma virus. Lamaline /00764901/ dosage: 2 To 6 Capsules A Day. During the same period patient was treated with ENBREL (50 Mg, Weekly) (View Enbrel Review and Enbrel Label ), NEXIUM (40 Mg, 1x/day) (View Nexium Review and Nexium Label ), MYOLASTAN (1 Df A Day) (View Myolastan Review and Myolastan Label ), CELEBREX (200 Mg, 1x/day) (View Celebrex Review and Celebrex Label ).


7724945-X | Cataract
on Aug 29, 2011 Female patient from FRANCE , 61 years of age, was diagnosed with pain (What is pain?), complex regional pain syndrome (What is complex regional pain syndrome?), neuralgia, insomnia and was treated with Lamaline(View Usage). Patient had the following side effects: cataract (What is cataract?). Lamaline dosage: 3 Df Daily. During the same period patient was treated with LYRICA (View Lyrica Review and Lyrica Label ), IMOVANE (7.5 Mg, 1x/day) (View Imovane Review and Imovane Label ).

7717516-2 | Bladder Prolapse
Patient was taking Lamaline (View Usage). After Lamaline was administered, patient had the following side effects: bladder prolapse on Aug 17, 2011 from FRANCE Additional patient health information: Female patient , 82 years of age, was diagnosed with sciatica (What is sciatica?), spinal fracture and. Lamaline dosage: 6 Df, Qd. During the same period patient was treated with PIASCLEDINE /01305801/ (1 Df, Qd) (View Piascledine /01305801/ Review and Piascledine /01305801/ Label ), UVEDOSE (1 Df, Qd) (View Uvedose Review and Uvedose Label ), FORTEO (20 Ug, Qd) (View Forteo Review and Forteo Label ), CALCIUM CARBONATE (2 Df, Qd) (View Calcium Carbonate Review and Calcium Carbonate Label ). Patient was hospitalized.

7469927-0 | Rheumatoid Arthritis
Adverse event was reported on May 06, 2011 by a Female patient taking Lamaline (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: FRANCE , weighting 175.3 lb, Patient experienced the following unwanted or unexpected effects: rheumatoid arthritis (What is rheumatoid arthritis?). During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), HERCEPTIN (Frequency: Per 3 Weeks) (View Herceptin Review and Herceptin Label ).

7426069-8 | Rheumatoid Arthritis
on Apr 14, 2011 Female patient from FRANCE , weighting 175.3 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Lamaline (View Usage). Patient had the following side effects: rheumatoid arthritis (What is rheumatoid arthritis?). Lamaline dosage: . During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), HERCEPTIN (Frequency: Per 3 Weeks) (View Herceptin Review and Herceptin Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ).

7351245-2 | Convulsion
on Mar 09, 2011 Female patient from FRANCE , 56 years of age, was diagnosed with neuralgia, hypercholesterolaemia, hypertension, prophylaxis and was treated with Lamaline(View Usage). After Lamaline was administered, patient had the following side effects: convulsion. Lamaline dosage: . During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), KERLONE (View Kerlone Review and Kerlone Label ), NEXIUM (View Nexium Review and Nexium Label ), LYRICA (75 Mg, 2x/day) (View Lyrica Review and Lyrica Label ).

5359057-6 | Asthenia, Fatigue
Patient was taking Lamaline (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, fatigue on Jun 04, 2007 from Additional patient health information: Female patient , 51 years of age, weighting 99.21 lb, was diagnosed with osteoporosis (What is osteoporosis?) and. Lamaline dosage: . During the same period patient was treated with FORTEO (20 Ug, Daily (1/d)) (View Forteo Review and Forteo Label ), LEVOTHYROXINE SODIUM (Unk, Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ANTIDEPRESSANTS (View Antidepressants Review and Antidepressants Label ).

5299250-4 | Anxiety, Cystitis, Dyspnoea, Eye Pain, Fall, Hyperthermia, Hyperthyroidism, Loss Of Consciousness
Adverse event was reported on Apr 03, 2007 by a Female patient taking Lamaline (View Usage) (Dosage: 1 Df, Once/single) was diagnosed with chronic myeloid leukaemia and. Location: FRANCE , 77 years of age, Patient had the following side effects: anxiety (What is anxiety?), cystitis, dyspnoea, eye pain, fall (What is fall?), hyperthermia, hyperthyroidism, loss of consciousness. During the same period patient was treated with DI ANTALVIC (View Di-antalvic Review and Di-antalvic Label ), GLEEVEC (300 Mg Daily) (View Gleevec Review and Gleevec Label ).

5024261-3 | Dermatitis Bullous, Pemphigus
on Jan 26, 2006 Female patient from FRANCE , 57 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Lamaline (View Usage). After Lamaline was administered, patient had the following side effects: dermatitis bullous, pemphigus (What is pemphigus?). Lamaline dosage: 1 Df, Tid. During the same period patient was treated with ATHYMIL (10 Mg, Qd) (View Athymil Review and Athymil Label ), VASTAREL (35 Mg, Bid) (View Vastarel Review and Vastarel Label ), BETAHISTINE (16 Mg, Bid) (View Betahistine Review and Betahistine Label ), BUSPAR (1 Df, Bid) (View Buspar Review and Buspar Label ), SANMIGRAN (View Sanmigran Review and Sanmigran Label ), FEMARA (2.5 Mg, Qd) (View Femara Review and Femara Label ). Patient was hospitalized.

4668551-2 | Hyperkalaemia, Metabolic Acidosis, Normochromic Normocytic Anaemia, Renal Failure Acute
on May 16, 2005 Female patient from , 76 years of age, was diagnosed with ill-defined disorder and was treated with Lamaline(View Usage). Patient experienced the following unwanted or unexpected effects: hyperkalaemia, metabolic acidosis, normochromic normocytic anaemia, renal failure acute. Lamaline dosage: . During the same period patient was treated with COVERSYL (View Coversyl Review and Coversyl Label ), ATHYMIL (View Athymil Review and Athymil Label ). Patient was hospitalized.